TIMELESS can be used as a pathological marker in colorectal cancer [35], etc. For breast cancer, TIMELESS regulates the ribosylation of ERα and activates cell proliferation-related signaling pathways by acting as a novel cofactor for Erα [28]. The gene discussed is TIMELESS; the disease is breast carcinoma.